Skip to main content
    I

    Indaptus Therapeutics Inc (INDP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.45
    +0.28 (+8.83%)

    Market Cap: $422.38M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Indaptus Therapeutics Inc (INDP) Earnings: Report Dates and Results

    Updated Nov 13, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Indaptus Therapeutics (INDP) is expected to report earnings on Mar 15, 2027. In the quarter ended Sep 30, 2026, Indaptus Therapeutics reported EPS of -$0.01. It beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    56%(20/36)
    Avg Surprise
    -5.97%

    Next Report

    INDP has an expected report date of Mar 15, 2027.

    Earnings History

    Of the 36 quarters below that had an estimate, INDP beat 20 and missed 16. The widest gap in the table came in the quarter ended Jun 30, 2021, when EPS landed 116.02% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.01N/AN/AN/AN/AN/AN/AN/ANov 13, 2026
    Jun 30, 2026-$0.02-$1.57-$1.57 - -$1.57N/AN/AN/A10 up, 0 downAug 13, 2026
    Dec 31, 2025-$9.19-$4.36-$4.36 - -$4.36-110.78%MissN/A10 up, 1 downMar 17, 2026
    Sep 30, 2025-$2.98-$4.17-$4.17 - -$4.17+28.54%BeatN/A10 up, 1 downNov 12, 2025
    Jun 30, 2025-$9.09-$9.24N/A+1.62%BeatN/AN/A0 up, 0 downAug 13, 2025
    Mar 31, 2025-$8.96-$5.04N/A-77.78%MissN/AN/A0 up, 0 downMay 14, 2025
    Dec 31, 2024-$0.37-$0.47N/A+21.28%BeatN/A10 up, 1 downMar 13, 2025
    Sep 30, 2024-$8.96-$13.16N/A+31.91%BeatN/A10 up, 0 downNov 12, 2024
    Jun 30, 2024-$13.16-$15.40N/A+14.55%BeatN/A10 up, 0 downAug 12, 2024
    Mar 31, 2024-$12.60-$15.96N/A+21.05%BeatN/A10 up, 0 downMay 8, 2024
    Dec 31, 2023-$0.48-$0.54-$0.54 - -$0.54+11.11%BeatN/A20 up, 0 downMar 13, 2024
    Sep 30, 2023-$13.16-$14.56N/A+9.62%BeatN/A10 up, 0 downNov 6, 2023
    Jun 30, 2023-$10.92-$16.24N/A+32.76%BeatN/A10 up, 0 downAug 14, 2023
    Mar 31, 2023-$0.51-$0.59-$0.59 - -$0.59+13.56%BeatN/A10 up, 0 downMay 11, 2023
    Dec 31, 2022-$12.32-$14.56N/A+15.38%BeatN/A10 up, 0 downMar 17, 2023
    Sep 30, 2022-$11.76-$14.28N/A+17.65%BeatN/A10 up, 0 downNov 10, 2022
    Jun 30, 2022-$12.88-$12.04N/A-6.98%MissN/A10 up, 0 downAug 8, 2022
    Mar 31, 2022-$0.41-$0.83-$1.27 - -$0.39+50.60%BeatN/A20 up, 0 downMay 12, 2022
    Dec 31, 2021-$6.16-$16.80N/A+63.33%BeatN/A20 up, 0 downMar 21, 2022
    Sep 30, 2021-$22.68-$15.40N/A-47.27%MissN/A1N/ANov 15, 2021
    Jun 30, 2021-$5.53-$2.56N/A-116.02%MissN/AN/AN/AAug 16, 2021
    Mar 31, 2021-$3.84-$3.48N/A-10.34%MissN/AN/AN/AMay 17, 2021
    Dec 31, 2020-$2.12-$3.40N/A+37.65%BeatN/AN/AN/AMar 16, 2021
    Sep 30, 2020-$3.80-$3.47N/A-9.51%MissN/AN/AN/ANov 5, 2020
    Jun 30, 2020-$4.00-$4.27N/A+6.32%BeatN/AN/AN/AAug 5, 2020
    Mar 31, 2020-$6.40-$6.13N/A-4.40%MissN/AN/AN/AMay 11, 2020
    Dec 31, 2019-$14.40-$12.00N/A-20.00%MissN/AN/AN/AMar 13, 2020
    Sep 30, 2019-$25.60-$17.40N/A-47.13%MissN/AN/AN/ANov 12, 2019
    Jun 30, 2019-$24.00-$24.16N/A+0.66%BeatN/AN/AN/AAug 9, 2019
    Mar 31, 2019-$25.60-$29.40N/A+12.93%BeatN/AN/AN/AMay 7, 2019
    Dec 31, 2018-$29.60-$24.16N/A-22.52%MissN/AN/AN/AFeb 27, 2019
    Sep 30, 2018-$22.40-$24.96N/A+10.26%BeatN/AN/AN/ANov 9, 2018
    Jun 30, 2018-$27.20-$26.08N/A-4.29%MissN/AN/AN/AAug 15, 2018
    Mar 31, 2018-$32.80-$22.67N/A-44.68%MissN/AN/AN/AMay 15, 2018
    Dec 31, 2017-$30.40-$22.00N/A-38.18%MissN/AN/AN/AMar 9, 2018
    Sep 30, 2017-$32.00-$27.20N/A-17.65%MissN/AN/AN/ANov 15, 2017
    Jun 30, 2017-$37.60-$24.80N/A-51.61%MissN/AN/AN/AAug 10, 2017
    Mar 31, 2017-$25.60-$29.60N/A+13.51%BeatN/AN/AN/AApr 7, 2017
    Dec 31, 2016Not reported-$0.30N/AN/ANot reportedN/AN/AN/AMar 29, 2017
    Sep 30, 2016-$4.30-$0.30N/AN/AN/AN/AN/AN/ADec 15, 2016
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$30.22, after -$35.09 the year before. It was -$34.70 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$30.22N/A
    Dec 31, 2024-$35.09N/A
    Dec 31, 2023-$25.07N/A
    Dec 31, 2022-$37.37N/A
    Dec 31, 2021-$38.21N/A
    Dec 31, 2020-$16.32N/A
    Dec 31, 2019-$89.60N/A
    Dec 31, 2018-$112.00N/A
    Dec 31, 2017-$125.60N/A
    Dec 31, 2016-$34.70N/A

    Frequently Asked Questions About INDP

    When is Indaptus Therapeutics's next earnings date?

    Indaptus Therapeutics's next earnings report is expected for Mar 15, 2027.

    How often does INDP beat earnings estimates?

    Indaptus Therapeutics beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate, with an average surprise of -8.70%.